Treatment:
angiotensin_2	S1046-p , S1184-p
BI2536	S1135-p , S1183-p , S1184-p , S1285-p , S1296-p
CXCL12	S1293-p
dasatinib	S973-p
EGF	S1184-p , S1278-p , S1297-p
ischemia	S737-p , S973-p , T975-p , S1225-p , S1244-p , S1293-p , S1346-p
lapatinib	Y1239-p , S1244-p
LRRK2-IN-1	S968-p , S973-p
metastatic potential	S1126-p
MLN8054	S905-p , S908-p , S911-p , S989-p
nocodazole	S968-p , S973-p , S1184-p , S1623-p , S1627-p , S1629-p
rapamycin	S1099-p , S1346-p
selumetinib	S1225-p
SII_angiotensin_2	S1278-p , S1293-p
vemurafenib	S1225-p , S1662-p
Y27632	T1097-p , S1099-p , S1115-p , S1244-p , S1277-p , S1278-p